Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Lenvatinib
Lenvatinib
417716-92-8
|
426.853
|
3.347
Lenvatinib is a receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma.
E7080 | lenvatinib | lenvima | levatinib
Lenvatinib is a receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma.
E7080 | lenvatinib | lenvima | levatinib
$120/5 mg
(EBC)
1
We provide 0 compound for Lenvatinib